Faculty Bibliography

Federal health officials on Feb 22, 1995 licensed the first vaccine in the US to prevent hepatitis A, a serious and common viral liver infection. The FDA said it gave SmithKline Beecham PLC approval to sell the vaccine, Havrix

Federal health officials Wednesday licensed the first vaccine in the United States to prevent hepatitis A, a serious and common viral liver infection that has plagued the Mid-South recently. The Food and Drug Administration said it gave SmithKline Beecham PLC approval to sell the vaccine. The company said it would begin distributing the vaccine, known as Havrix, in the next several weeks. Dr. Sherman Kahn, the Memphis and Shelby County Health Department's health officer, said the department is eager to learn more about the vaccine's availability and its recommended use. By Wednesday, 139 cases of hepatitis A had been reported locally in the most recent outbreak, including 28 requiring hospitalization

Hepatitis A can cause loss of appetite, fatigue, fever, muscle aches, nausea and vomiting, which are often followed one to two weeks later by a yellowing of the skin known as jaundice. The yellowing is a result of a buildup of bile pigments in the blood that follows the liver damage from the hepatitis. Many people suffer mild hepatitis A infections without jaundice

Summary: The procedure on the optic nerve to correct a sudden vision loss is possibly harmful, federal officials determine An eye operation routinely done to correct the most common cause of sudden loss of vision in people 60 and older has been found to be so ineffective, and possibly harmful, that federal health officials are warning eye surgeons to stop doing the procedure. The eye condition, known as non-arteritic ischemic optic neuropathy, comes on so suddenly that those affected by it often awake with their vision gone in one eye

An eye operation routinely done to correct the most common cause of sudden loss of vision in people 60 and older has been found to be so ineffective, and possibly harmful, that federal health officials are warning eye surgeons to stop doing the procedure. The eye condition, known as non-arteritic ischemic optic neuropathy, comes on so suddenly that those affected by it often awake with their vision gone in one eye. In 40 percent of those affected, loss of vision can eventually develop in both eyes. The condition results from a painless swelling of the optic nerve that connects the eye and the brain

An eye operation routinely done to correct nonarteritic ischemic optic neuropathy--the most common cause of sudden loss of vision in people 60 and older--has been found to be so ineffective, and possibly harmful, that federal health officials, in a Feb 22, 1995 report in the Journal of the American Medical Association, are warning eye surgeons to stop doing the procedure. The study found that those who had no treatment at all recovered their vision after a period of six months at a considerably higher rate than those who had the surgery

Summary: A federal study says the surgery to relieve pressure on the optic nerve is ineffective and may make things worse An eye operation routinely done to correct the most common cause of sudden loss of vision in people 60 and older has been found to be so ineffective, and possibly harmful, that federal health officials are warning eye surgeons to stop doing the procedure. The eye condition, known as non-arteritic ischemic optic neuropathy, comes on so suddenly that those affected by it often awake with their vision gone in one eye

An eye operation routinely done to correct the most common cause of sudden loss of vision in people 60 and older has been found to be so ineffective, and possibly harmful, that federal health officials are warning eye surgeons to stop doing the procedure. The eye condition, known as nonarteritic ischemic optic neuropathy, comes on so suddenly that those affected by it often awake with their vision gone in one eye. In 40 percent of those affected, loss of vision can eventually develop in both eyes. The condition results from a painless swelling of the optic nerve that connects the eye and the brain

An eye operation routinely done to correct the most common cause of sudden loss of vision in people 60 and older has been found to be so ineffective, and possibly harmful, that federal health officials are warning eye surgeons to stop doing the procedure. The eye condition, known as nonarteritic ischemic optic neuropathy, comes on so suddenly that those affected by it often awake with their vision gone in one eye. In 40 percent of those affected, loss of vision can eventually develop in both eyes. The condition results from a painless swelling of the optic nerve that connects the eye and the brain

Findings from the study, believed to be the largest of its kind, point to biases in how doctors choose the pacemakers they implant in patients, the authors said Tuesday in Circulation, a medical journal of the American Heart Association in Dallas. However, the study wasn't designed to determine the cause of any such biases, the authors said